Manganese, Metallurgical Safety Data Sheet

Format: GHS Revised: April 24, 2015 

Language: English (US) Version 2 

Page 1 of 16

1.1 Product Identifier

Product Name: Manganese, Metallurgical 

Product Form: Solid 

Chemical Family: Metal Ore

CAS Number: 7439-96-5 (for Manganese)

Molecular Formula: See Section 3.1. 

Molecular Weight: Varies. See Section 3.1. 

1.2 Other Means of Identification

Synonyms: DLA13623

1.3 Recommended Uses

Recommended Use: Alloy

1.4 Manufacturer, Importer, or Responsible Party

Responsible Party:

1.5 Emergency Phone Number

Emergency Phone Number: 

Defense Logistics Agency Strategic Materials

8725 John J. Kingman Road

Fort Belvoir, Virginia 22060-6223

(571) 767-5525

(800) 424-9300 (CHEMTREC)

(703) 527-3887 (CHEMTREC INTERNATIONAL)

2.1 Classification of Chemical per OSHA CFR 1910.1200

Skin Irritation: Category 2

Eye Irritation: Category 2B

Respiratory Sensitization: Category 1A

Carcinogenicity: Category 1A

Reproductive Toxicity: Category 1A

Target Organ- Prolonged: Category 1 (Nervous Systems)

2.2 Label Elements

Signal Word: DANGER

Section 1: Identification

Section 2: Hazard(s) Identification

Manganese, 

Metallurgical

Safety Data Sheet
Manganese, Metallurgical Safety Data Sheet

Format: GHS Revised: April 24, 2015 

Language: English (US) Version 2 

Page 2 of 16

Symbol(s):

Hazard Statements: Causes skin and eye irritation. May cause eye damage. May cause allergy or 

asthma symptoms, breathing difficulties, changes in body temperature, metal 

fume fever, nausea, vomiting, diarrhea or headache if inhaled. May cause 

cancer. May damage fertility or the unborn child. Causes damage to the 

nervous system through prolonged or repeated exposure. 

Precautionary Statements: Prevention: Obtain special instructions before use. Do not handle until all safety 

precautions have been read and understood. Wear protective gloves, 

protective clothing, eye protection, and face protection. Wash thoroughly after 

handling. Do not breathe dust, fume, vapors, and spray. In case of inadequate 

ventilation, wear respiratory protection. Do not eat, drink, or smoke when using 

this product. 

Response: If on skin, wash with plenty of water. If skin irritation occurs, get 

medical advice and/or attention. Take off contaminated clothing and wash it 

before reuse. If in eyes, rinse cautiously with water for several minutes. 

Remove contact lenses, if present and easy to do. Continue rinsing. If eye 

irritation persists, get medical advice and/or attention. If inhaled and breathing 

is difficult, remove person to fresh air and keep comfortable for breathing. If 

experiencing respiratory symptoms, call a doctor. If exposed or concerned, get 

medical advice and/or attention. Get medical advice and/or attention if you feel 

unwell. In case of fire: Use dolomite, dry powder for metal fires, dry sand, 

graphite, soda ash, sodium chloride to extinguish. 

Storage: Store locked up. Store in a dry place. Store in a closed container.

Disposal: Dispose of contents in accordance with local, regional, national, and 

international regulations.

2.3 Other Hazards

Negligible fire and explosion hazard in bulk form. Dust/air mixtures may ignite or explode.

2.4 Unknown Acute Toxicity

Does not apply to this product.

3.1 Composition 

Chemical Name:

Composition: 

Manganese, Metallurgical-Grade Ore

20.7% Mn (wtd. av.) 

The health and physical hazards information provided in this SDS are for its major component. Manganese MetallurgicalGrade Ore contains other elements in addition to Mn. For concentrations of other components, see the Certificates of 

Analysis for each lot.

3.2 Common Names/Synonyms

Synonyms: See Section 1.2 for common names and synonyms.

3.3 CAS Number/Unique Identifiers

CAS Number: 7439-96-5 (for Manganese)

3.4 Impurities/Stabilizing Additives

No data available.

Section 3: Composition / Information on Ingredients

Section 4: First-Aid Measures
Manganese, Metallurgical Safety Data Sheet

Format: GHS Revised: April 24, 2015

Language: English (US) Version 2

Page 3 of 16

4.1 Description of First-Aid Measures

Inhalation: If adverse effects occur, remove to uncontaminated area. Give artificial 

respiration if not breathing. Get immediate medical attention.

Skin Contact: Wash skin with soap and water for at least 15 minutes. Remove contaminated 

clothing and shoes. Get medical attention, if needed. Thoroughly clean and 

dry contaminated clothing and shoes before reuse.

Eye Contact: Flush eyes with plenty of water for at least 15 minutes. Get immediate medical 

attention. 

Ingestion: If a large amount is swallowed, get medical attention. 

4.2 Most Important Symptoms/Effects, Acute and Delayed

Inhalation (Acute): Irritation, changes in body temperature, metal fume fever, nausea, vomiting, 

diarrhea, chest pain, difficulty breathing, headache

Inhalation (Chronic): Irritation, cough, loss of appetite, weight loss, chest pain, difficulty breathing, 

disorientation, difficulty speaking, sleep disturbances, emotional disturbances, 

hallucinations, mood swings, tremors, muscle cramps, loss of coordination, 

hearing loss, visual disturbances, bluish skin color, lung congestion, lung 

damage, blood disorders, kidney damage, liver damage, nerve damage, and 

cancer.

Skin Contact (Acute): Irritation.

Skin Contact (Chronic): Irritation and skin disorders.

Eye Contact (Acute): Irritation, eye damage.

Eye Contact (Chronic): Irritation, eye damage.

Ingestion (Acute): Gastrointestinal irritation, nausea, vomiting, and diarrhea.

Ingestion (Chronic): Drowsiness.

4.3 Indication of Immediate Medical Attention/Special Treatment

Seek immediate medical attention if inhaled, exposed to eyes, and/or ingested.

5.1 Suitable Extinguishing Media

Dolomite, dry powder for metal fires, dry sand, graphite, soda ash, and sodium chloride.

5.2 Specific Hazards

Negligible fire and explosion hazard in bulk form. Dust/air mixtures may ignite or explode.

5.3 Special Protective Equipment and Precautions

Protect container from physical damage. Move container from fire area if it can be done without risk. Cool containers 

with water spray until well after the fire is out. Stay away from the ends of tanks. For fires in cargo or storage area: Cool 

containers with water from unmanned hose holder or monitor nozzles until well after fire is out. If this is impossible then 

take the following precautions: Keep unnecessary people away, isolate hazard area and deny entry. Let the fire bum. 

Use extinguishing agents appropriate for surrounding fire. Avoid inhalation of material or combustion by-products.

6.1 Personal Precautions, Protective Equipment, and Emergency Procedures

Subject to California Safe Drinking Water and Toxic Enforcement Act of 1986 (Proposition 65). Notify Local Emergency 

Planning Committee and State Emergency Response Commission for release greater than or equal to RQ (U.S. SARA 

Section 304). If release occurs in the U.S. and is reportable under CERCLA Section 103, notify the National Response 

Center at (800) 424-8802 (USA) or (202) 426-2675 (USA). Keep out of water supplies and sewers. Keep all 

unauthorized people away, isolate hazard area, and deny entry. Personal protective equipment is discussed in Section 

8.3.

6.2 Methods and Materials for Containment and Cleaning Up

Section 5: Fire Fighting Measures

Section 6: Accidental Release Measures
Manganese, Metallurgical Safety Data Sheet

Format: GHS Revised: April 24, 2015

Language: English (US) Version 2

Page 4 of 16

Collect spilled material in appropriate container for disposal. 

7.1 Precautions for Safe Handling

Use methods to minimize dust. High standard of personal cleanliness and hygiene is essential. Adequate sanitary 

facilities, clothing, and time must be provided so that compulsory showering after work is completed. A change of clothes 

and ban on eating and smoking at work place can be effective. Personal protective equipment is discussed in Section 

8.3.

7.2 Conditions for Safe Storage

Store in accordance with all current regulations and standards. See original container for storage recommendations. 

Keep separated from incompatible substances. Incompatible materials are identified in Section 10.5.

8.1 Exposure Limits

Exposure Limits: Manganese, Metallurgical

If an employee is exposed to lead for more than 8 hours in any work day, the permissible exposure limit, as a time 

weighted average (TWA) for that day, shall be reduced according to the following formula: Maximum permissible limit (in 

ug/m3)=400 divided by hours worked in the day. 

Manganese, Manganese and Compounds (as Mn)

OSHA PEL Ceiling: 5 mg/m3 (metal) (fume) (compounds)

OSHA TWA (particulate) (vacated by 58 FR 35338, June 30, 1993)

OSHA STEL (particulate) (vacated by 58 FR 35338, June 30, 1993)

ACGIH TWA (2013): 0.02 mg/m3 (metal and inorganic compounds) (respirable fraction)

ACGIH TWA: 0.1 mg/m3 (metal and inorganic compounds) (inhalable fraction)

NIOSH REL TWA (10 hours): 1 mg/m3 (metal) (fume) (compounds) 

NIOSH REL STEL: 3 mg/m3 (metal) (fume) (compounds)

DFG MAK: 0.5 mg/m3 (inhalable fraction) (metal and inorganic compounds)

UK WEL TWA: 0.5 mg/m3 (metal) (inorganic compounds)

ACGIH Excursion Limit Recommendation: Excursions in worker exposure levels may exceed 3 times the TLV-TWA 

for no more than a total of 30 minutes during a work day, and under no circumstances should they exceed 5 times the 

TLV-TWA, provided that the TLV-TWA is not exceeded.

Measurement method: NIOSH IV #7300, 7301, 7303, 9102; OSHA #ID121, ID135G

Iron Oxide Dust and Fume (as Fe): 

OSHA TWA: 10 mg/m3

ACGIH TWA: 5 mg(Fe2O3)/m3 (total particulate)

NIOSH TWA: 5 mg/m3 10 hour(s) (total particulate)

DFG MAK: 1.5 mg/m3 (respirable fraction)

UK WEL TWA: 5 mg/m3

UK WEL STEL: 10 mg/m3

Measurement method: NIOSH IV# 7300, 7301, 7303, 9102; OSHA # ID121, ID125G

Aluminum Oxide (Alumina): 

OSHA TWA: 5 mg/m3 (respirable dust fraction)

OSHA TWA: 15 mg/m3 (total dust)

OSHA TWA: 10 mg/m3 (total particulate) (vacated by 58 FR 35338, June 30, 1993)

ACGIH TWA: 1 mg/m3 (respirable fraction) (insoluble compounds)

DFG MAK: 1.5 mg/m3 (respirable dust fraction)

DFG MAK: 4 mg (AL)/m3 (inhalable dust fraction)

AGS TRK: 0.25 fibers/cc (fibrous forms) (effective 1 Jan 2005 no longer valid per 

Section 7: Handling and Storage

Section 8: Exposure Controls / Personal Protection
Manganese, Metallurgical Safety Data Sheet

Format: GHS Revised: April 24, 2015

Language: English (US) Version 2

Page 5 of 16

amendment)

UK WEL TWA: 10 mg/m3 (total inhalable dust)

UK WEL TWA: 4 mg/m3 (respirable dust)

Measurement Method: NIOSH IV #0500, 0600; OSHA ID109SG, ID198SG

Silicon Dioxide, Amorphous (Silica, Amorphous):

OSHA TWA: 20 mppcf (<1% crystalline silica)

OSHA TWA: 80 mg/m3 divided by %SiO2 (<1% crystalline silica)

NIOSH recommended TWA: 6 mg/m3 recommended TWA 10 hr.(s)

DFG MAK: 0.3 mg/m3 (respirable fraction)

DFG MAK: 4 mg/m3 (inhalable fraction)

UK WEL TWA: 6 mg/m3 (total inhalable dust)

UK WEL TWA: 2.4 mg/m3 (respirable dust)

Measurement Method: NIOSH IV #7501

Lead, Inorganic Fumes and Dust (as Pb): 

OSHA TWA (8 hours): 50 μg/m3

OSHA Action Level: 30 μg/m3

ACGIH TWA: 0.05 mg/m3 (metal and inorganic compounds)

NIOSH TWA: 0.050 recommended TWA 10 hour(s) (metal and compounds)

ED OEL TWA (BOELV): 0.15 mg/m3

Measurement Method: NIOSH IV # 7082, 7105, 7300, 7301, 7303, 7700, 7701, 7702, 9102, 9105; OSHA ID121, ID 125G, 

ID206 .

8.2 Appropriate Engineering Controls

Ventilation: Provide local exhaust ventilation system. Ensure compliance with applicable 

exposure limits.

8.3 Individual Protection Measures

Eye Protection: Wear splash resistant safety goggles. Provide an emergency eyewash

fountain and quick drench shower in the immediate work area.

Clothing: Wear appropriate chemical resistant clothing.

Gloves: Wear appropriate chemical resistant gloves.

Respirator: Under conditions of frequent use or heavy exposure, respiratory protection 

may be needed. Respiratory protection is ranked in order from minimum to 

maximum. Consider warning properties before use.

1. Any particulate respirator equipped with an N95, R95, or P95 filter (including 

N95, R95, and P95 filtering face pieces) except quarter-mask respirators. The 

following filters may also be used: N99, R99, P99, N100, R100 or P100.

2. Any air powered, air-purifying respirator with high-efficiency particulate filter.

3. Any powered, air-purifying respirator with a tight-fitting face piece and a 

high- efficiency particulate filter.

4. Any powered air-purifying respirator with a full face piece that is operated in 

a pressure-demand or other positive pressure mode.

Unknown Concentrations/IDLH: 1. Any self-contained breathing apparatus that has a full face piece and is 

operated in a pressure-demand or other positive-pressure mode in 

combination with an auxiliary self-contained breathing apparatus operated in 

pressure-demand or other positive-pressure mode.

2. Any supplied-air respirator that has a full face piece and is operated in a 

pressure-demand or other positive-pressure mode.
Manganese, Metallurgical Safety Data Sheet

Format: GHS Revised: April 24, 2015

Language: English (US) Version 2

Page 6 of 16

9.1 Appearance

Physical State: Solid

Physical Description: Reddish-gray or silvery, brittle, metallic solid

9.2 Odor

No data available.

9.3 Odor Threshold

No data available.

9.4 pH

Not applicable.

9.5 Melting/Freezing Points

Melting Point: No data available.

Freezing Point: No data available.

9.6 Initial Boiling Point and Boiling Range

Not applicable.

9.7 Flash Point

No data available. 

9.8 Evaporation Rate

Not applicable.

9.9 Flammability

No data available.

9.10 Upper/Lower Explosive Limits

No data available.

9.11 Vapor Pressure

Not applicable.

9.12 Vapor Density

Not applicable.

9.13 Relative Density

No data available.

9.14 Water Solubility(ies)

Insoluble.

9.15 Partition Coefficient

No data available.

9.16 Auto-Ignition Temperature

No data available.

9.17 Decomposition Temperature

No data available.

9.18 Viscosity

No data available.

 

 9.19 Solvent Solubility: 

Section 9: Physical and Chemical Properties
Manganese, Metallurgical Safety Data Sheet

Format: GHS Revised: April 24, 2015

Language: English (US) Version 2

Page 7 of 16

 Soluble: mineral acids

10.1 Reactivity

Stable at normal temperatures and pressure. 

10.2 Chemical Stability

Stable at normal temperatures and pressures.

10.3 Possibility of Hazardous Reactions

Manganese

Aluminum (Dust): Forms explosive mixtures with air. 

Ammonium Nitrate (Fused): Violent or explosive reaction. 

Bromine Pentafluoride: Violent reaction and possible ignition. 

Carbon Dioxide: Ignites.

Chlorine: Ignites.

Fluorine: Incandescent reaction.

Hydrogen Peroxide: Violent decomposition and/or ignition. 

Nitric Acid: Incandescent reaction and feeble explosion.

Nitrogen Dioxide: Ignition.

Oxidizers (Strong): Fire and explosion hazard. 

Phosphorus: Incandescent reaction when heated. 

Sulfur Dioxide: Burns brilliantly on warming.

Iron

Acetaldehyde: Polymerizes readily

Ammonium Nitrate: Violent or explosive reaction. 

Ammonium Peroxodisulfate: Violent reaction. 

Bromine Pentaflouride: Violent reaction and possible ignition. 

Chloric Acid: Forms explosive compound.

Chlorine (Gas): Ignites. 

Chlorine Triflouride: Violent reaction and possible ignition.

Chloroformamidinium Nitrate: Explosive ignition. 

Dinitrogen Tetraoxide: Ignites.

Fluorine: Ignites.

Hydrogen Peroxide: Violent decomposition.

Mineral Acids: Readily attacked.

Nitrogen Dioxide: Incandescent reaction.

Nitryl Fluoride: Incandesces when heated. 

Organic Acids: Attacked or dissolved. 

Peroxyformic Acid: Incompatible.

Phosphorus: Incandesces when heated

Polystyrene Beads: Possible static ignition. 

Potassium Dichromate: Ignites on contact.

Potassium Perchlorate +

Manganese Dioxide: Ignites.

Sodium Acetylide: Possible violent reaction. 

Sodium Peroxide: Ignites under friction @ 240 C. 

Sulfuric Acid: Possible explosion hazard.

Aluminum Oxide (Alumina)

Chlorinated Rubber (Hot): Incompatible. 

Chlorine Triflouride: Violent reaction and possible ignition. 

Ethylene Oxide: May initiate explosive polymerization. 

Halocarbons: Exothermic reaction above 200 C. 

Halocarbons + Metals: Exothermic reaction at ambient temperatures. 

Oxygen Difluoride: Exothermic reaction.

Section 10: Stability and Reactivity
Manganese, Metallurgical Safety Data Sheet

Format: GHS Revised: April 24, 2015

Language: English (US) Version 2

Page 8 of 16

Sodium Nitrate: May form explosive mixture. 

Vinyl Acetate: Possible vigorous reaction. 

Silicon Dioxide

Chlorine Triflouride: Fire hazard. 

Fluorine: Fire hazard. 

Hydrochloric Acid + Water: Explosion hazard with gel form. 

Hydrofluoric Acid: Dissolves, releasing silicon tetrafluoride. 

Hydrogen Fluoride: Incompatible. 

Hydrogenated Vegetable Oils: Incompatible.

Magnesium (Powdered): Explosion hazard on heating in the presence of moisture. 

Manganese Triflouride: May react violently on heating, releasing silicon tetrafluoride

Oxidizers (strong): Fire and explosion hazard.

Oxygen Difluoride: Explosion hazard under certain conditions and in the presence of moisture. 

Ozone: Potential explosion hazard at low temperatures if organic material is present. 

Phosphoric Acid (concentrated): Attacks on heating. 

Sodium (burning): Reacts with finely divided silica. 

Vinyl Acetate (Vapor): May react vigorously with gel form. 

Xenon Hexafluoride: May react explosively by forming xenon trioxide. 

. 

10.4 Conditions to Avoid

None reported.

10.5 Incompatible Materials

Metals, oxidizing materials, halogens, peroxides, combustible materials, acids, bases, halocarbons, metal salts.

Safe storage of the material is discussed in Section 7.2.

10.6 Hazardous Decomposition Products

Thermal Decomposition Products: Miscellaneous Decomposition Products

10.7 Polymerization 

Will not polymerize. 

11.1 Likely Routes of Exposure

Routes of entry include inhalation, skin contact, eye contact, and ingestion. 

11.2 Symptoms

See Section 4.2 for symptoms related to the physical, chemical, and toxicological characteristics.

11.3 Short and Long Term Effects

Inhalation (Aluminum Oxide, 

Alumina): Inhalation of high concentrations may cause coughing, shortness of breath, 

respiratory tract irritation due to mechanical action, unpleasant deposits in 

the nasal passages, and exacerbation of symptoms in persons with impaired 

pulmonary function. Humans exposed chronically to aluminum oxide, particle 

size approximately 1.2 microns, did not experience either systemic or 

respiratory adverse effects. Hydrated aluminum oxide, injected 

intratracheally, produced dense and numerous nodules of advanced fibrosis 

in rates, a reticulin network with occasional collagen fibers in mice and 

Guinea pigs, and only a slight reticulin network in rabbits. A production 

process in which aluminum oxide (bauxite), iron, coke, and silica are fused at 

2000 C poses a threat of Shaver’s disease, a rapidly progressive and often 

fatal interstitial fibrosis of the lungs. See information on metal fume fever.

Acute Exposure (Manganese): Dust or fumes may be irritating to the mucous membranes. Occupational 

Section 11: Toxicological Information
Manganese, Metallurgical Safety Data Sheet

Format: GHS Revised: April 24, 2015

Language: English (US) Version 2

Page 9 of 16

exposure to dust or fumes has been reported to cause upper respiratory tract 

problems, black mucous membrane discharge from the nose, and neurological 

damage. Metal fume fever, an influenza-like illness, may occur due to the 

inhalation of freshly formed metal oxide particles sized below 1.5 microns and 

usually between 0.02-0.05 microns. Symptoms may be delayed 4-12 hours 

and begin with a sudden onset of thirst, and a sweet, metallic or foul taste in 

the mouth. Other symptoms may include upper respiratory tract irritation 

accompanied by coughing and a dryness of the mucous membranes, lassitude 

and a generalized feeling of malaise. Fever, chills, muscular pain, mild to 

severe headache, nausea, occasional vomiting, exaggerated mental activity, 

profuse sweating, excessive urination, diarrhea and prostration may also 

occur. Tolerance to fumes develops rapidly, but is quickly lost. All symptoms 

usually subside within 24-36 hours.

Acute Exposure (Iron): Dust may cause mucous membrane and respiratory irritation due to 

mechanical action. Metal fume fever, an influenza-like illness, may occur due 

to the inhalation of freshly formed iron oxide particles sized below 1.5 microns 

and usually between 0.02 and 0.05 microns. Symptoms may be delayed 4-12 

hours and begin with a sudden onset of thirst, and a sweet, metallic or foul 

taste in the mouth. Other symptoms may include upper respiratory tract 

irritation accompanies by coughing and a dryness of the mucous membranes. 

Lassitude and a generalized feeling of malaise. Fever, chills, muscular paid, 

mild to severe headache, nausea, occasional vomiting, exaggerated mental 

activity, profuse sweating, excessive urination, diarrhea, and prostration may 

also occur. Tolerance to fumes develops rapidly, but is quickly lost. All 

symptoms usually subside within 24-36 hours. 

Acute Exposure (Metal Fume Fever): Metal fume fever, an influenza-like illness, may occur due to the inhalation of 

freshly formed metal oxide particles sized below 1.5 micros and usually 

between 0.02-0.05 microns. Symptoms may be delayed 4-12 hours and begin 

with a sudden onset of thirst, and a sweet, metallic or foul taste in the mouth. 

Other symptoms may include upper respiratory tract irritation accompanies by 

coughing and a dryness of the mucous membranes. Lassitude and a 

generalized feeling of malaise. Fever, chills, muscular paid, mild to severe 

headache, nausea, occasional vomiting, exaggerated mental activity, profuse 

sweating, excessive urination, diarrhea, and prostration may also occur.

Tolerance to fumes develops rapidly, but is quickly lost. All symptoms usually 

subside within 24-36 hours. 

Acute Exposure (Silicon Dioxide): Dusts may cause irritation of the respiratory tract and coughing. 

Acute Exposure (Quartz): Exposure to high concentrations may cause physical discomfort of the upper 

respiratory tract. 

Chronic Exposure (Manganese): If sufficient quantities of manganese dust or fumes are inhaled and absorbed, 

systemic poisoning known as "manganism", a Parkinsonian-like syndrome 

may occur. It is characterized initially by anorexia, asthenia, headache, 

insomnia or somnolence, irritability, restlessness, and spasm or pain in the 

muscles. Manganese psychosis may follow with uncontrollable behavior, 

unaccountable laughing or crying, visual hallucinations, confusion and 

euphoria. Sexual excitement followed by impotence may occur. These 

symptoms may disappear with the onset of true neurological manifestations of 

slow, slurred and irregular speech, monotonous tone, double vision, impaired 

hearing, and difficulty with fine motor movements, and disturbances in gait and 

balance with frequent propulsion or retropulsion. Mask-like face, decreased 

movement of the eyelids and eyes and tremors of the upper extremities and 

head may also occur. Other signs and symptoms may include urinary bladder 

disturbances, excessive salivation and sweating, hematological changes, 

vasomotor disorders, decreased pulmonary function, kidney and possibly liver 

damage. Removal from exposure shortly after onset of symptoms usually 

results in improvement, although there may be residual disturbances in gait 

and speech. Once manganism is well established it becomes irreversible and 

progressive, but not fatal. An increased incidence of bronchitis and 

pneumonitis has been reported in studies of workers exposed to manganese 

dust and fume, and although these effects have been confirmed by animal 
Manganese, Metallurgical Safety Data Sheet

Format: GHS Revised: April 24, 2015

Language: English (US) Version 2

Page 10 of 16

experiments, they may represent an aggravation of a pre- existing condition. 

Allergic diseases of the respiratory tract have also been reported in one study.

Chronic Exposure (Iron): Prolonged or repeated exposure may cause a mottling of the lungs, a condition 

called siderosis which is considered to be a benign pneumoconiosis that does 

not cause significant physiologic impairment. Symptoms may include chronic 

bronchitis, emphysema, and dyspnea on exertion. 

Chronic Exposure (Metal Fume Fever): There is no form of chronic metal fume fever, however, repeated bouts with 

symptoms as described above are quire common. Resistance to the condition 

develops after a few days of exposure, but is quickly lost in 1 or 2 days. 

Chronic Exposure (Silicon Dioxide): Exposure to dusts of crystalline or amorphous silica for 6 months to 30 years 

may result in silicosis with symptoms of cough, chest pain, dyspnea, 

tachypnea, marked weakness and weight loss. The is pulmonary insufficiency 

may be characterized by diffuse nodular fibrosis, distortion of bronchi, 

diminished chest expansion, decreased vital capacity and compensatory and 

bullous emphysema. Although pulmonary fibrosis has been reported from 

workers exposed to amorphous silica, the crystalline form is the established 

cause of fibrotic response in the lung. However, the amorphous form has been 

reported fibrogenic to a lesser extent. As the disease progresses, cor 

pulmonale, cardiorespiratory failure, and death may occur. Various forms and 

preparations of crystalline silica produced adenocarcinomas and squamous 

cell carcinomas of the lungs in rats. 

Chronic Exposure (Quartz): Inhalation of very high concentrations of finely divided crystalline silica dust, 

exposure ranging from a few weeks to 4-5 years, may cause a rapidly 

developing silicosis, characterized by pulmonary insufficiency with sever 

dyspnea, violent coughing, tachypnea, weight loss, and cyanosis leading to 

the development of cor pulmonale and death within a relatively short period of 

time. A slowly developing silicosis may result from exposure for 6 motnhs-30 

years relatively low levels of the dust. The first symptom is usually a slowly 

increasing, non-disabling, exertional dyspnea due to pulmonary fibrosis and 

the emphysema associated with it. Continued exposures may increase the 

rate of progression of the disease. Also, the fibrogenic action may continue 

when exposure ceases. As the fibrosis advances, other symptoms may 

include shortness of breath, productive cough, wheezing, chest tightness or 

pain, marked weakness, decreased capacity for work, and repeated nonspecific chest illnesses. Cyanosis, clubbing of digits, orthopnea, or serious 

weight loss are not usually evident until the disease is advanced. Pulmonary 

infections, which may be indicated by hemoptysis, and cardiac 

decompensation may exacerbate the symptoms. Three major complications, 

which are the most frequent causes of death, are pulmonary tuberculosis, 

respiratory insufficiency which is due to the massive emphysematous and 

fibrotic changes and is sometimes accompanied by chronic cor pulmonale, 

and acute bronchopulmonary risk for dying from lung cancer. This increase 

has been seen among miners, quarry workers, foundry workers, ceramic 

workers, granite workers, and stonecutters. In some of these studies, the risk 

of lung cancer increased with the duration of employment. Various forms and 

preparations of crystalline silica produced adenocarcinomas and squamous 

cell carcinomas of the lungs in rats. 

Skin Contact

Acute Exposure (Manganese): 500 mg applied to the skin of rabbits caused mild irritation.

Acute Exposure (Iron): Dust may cause irritation. Penetration of iron particles in the skin may cause 

an exogenous siderosis which may be characterized by a red-brown 

pigmentation of the affected area. 

Acute Exposure (Aluminum Oxide,

Alumina): Contact may cause an irritant dermatitis accompanied by pruritus. 

Acute Exposure (Silicon Dioxide): Prolonged skin contact with dry particulate may cause drying of the skin. 

Acute Exposure (Quartz): May cause irritation of intact skin due to mechanical abrasion. If the skin is 

abraded, a heavy growth of scar tissue may be induced. 
Manganese, Metallurgical Safety Data Sheet

Format: GHS Revised: April 24, 2015

Language: English (US) Version 2

Page 11 of 16

Chronic Exposure (Manganese): Sensitization has been reported in guinea pigs.

Chronic Exposure (Iron): May cause same effects as reported in acute exposure.

Chronic Exposure (Aluminum Oxide,

Alumina): No data available. 

Chronic Exposure (Silicon Dioxide): No data available.

Chronic Exposure (Quartz): No data available.

Eye Contact

Acute Exposure (Manganese): Dust or fumes may be irritating to the eyes. 500 mg applied to the eyes of 

rabbits caused mild irritation.

Acute Exposure (Iron): May cause irritation due to mechanical action. Iron particles imbedded in the 

eye may cause ocular siderosis. Effect may include discoloration of the cornea 

and iris, and pupillary effects including poor reaction to light and 

accommodation. If particle enters the lens there may be cataract formation. 

Glaucoma occurs rarely in some cases of ocular siderosis. 

Acute Exposure (Aluminum Oxide,

Alumina): Dust may cause mechanical irritation with redness and possibly swelling of the 

conjunctiva. 

Acute Exposure (Silicon Dioxide): Dusts may cause irritation with redness and pain. 

Acute Exposure (Quartz): May cause irritation due to mechanical action. Particles of silica in the range 

of 2-3 micrometers introduced into the corneal stroma of rabbit eyes caused 

very little reaction. These same particles introduced into the anterior chamber 

resulted in an inflammatory reaction in 3-5 weeks with the formation of fibrotic 

nodules in the iridocorneal angle. Finely divided silica injected into the vitreous 

of rabbit eyes has caused necrosis of the retina and atrophy of the choroid.

Chronic Exposure (Manganese): Fumes may cause conjunctivitis.

Chronic Exposure (Iron): Repeated or prolonged contact may cause conjunctivitis and other effects 

reported in acute exposure. 

Chronic Exposure (Aluminum Oxide,

Alumina): No data available. 

Chronic Exposure (Silicon Dioxide): No data available. 

Chronic Exposure (Quartz): An abnormally high silicon content in the cornea, and a gradual decrease in 

visual acuity due to corneal opacities in the pupillary area, have been reported 

in a group of foundry workers. 

Ingestion

Acute Exposure (Manganese): Extremely large doses may cause gastrointestinal irritation and possibly 

systemic toxicity.

Acute Exposure (Iron): There are no reports available on poisoning from metallic iron, which is poorly 

absorbed. The principal manifestations of poisoning with iron compounds are 

vomiting, diarrhea, and circulatory collapse. 

Acute Exposure (Aluminum Oxide,

Alumina): Not data available. 

Acute Exposure (Silicon Dioxide): The effects of ingestion are purely mechanical as the substance is inert 

chemically and biologically. 

Acute Exposure (Quartz): Effects of ingestion are due to mechanical action as crystalline silicas are 

biologically inert. 

Chronic Exposure (Manganese): Manganese poisoning has been reported in persons drinking manganesecontaminated well water. Prolonged ingestion of manganese in water has 

produced lethargy, edema, and decreased movement of the eyes and eyelids.

Chronic Exposure (Iron): Repeated or prolonged exposure may cause hemosiderosis or 

hemochromatosis.

Chronic Exposure (Aluminum Oxide, 

Alumina): Some aluminum compounds cause constipation. 

Chronic Exposure (Silicon Dioxide): No data available.

Chronic Exposure (Quartz): No data available.

11.4 Numerical Measures of Toxicity

Manganese
Manganese, Metallurgical Safety Data Sheet

Format: GHS Revised: April 24, 2015

Language: English (US) Version 2

Page 12 of 16

Irritation Data: 500 mg/24 hour(s) skin-rabbit mild 

500 mg/24 hour(s) eyes-rabbit mild 

Toxicity Data: 2,300 μg/m3 inhalation-man TCLo; 9 gm/kg oral-rat LD50; 3,709 mg/m3/6 

hour(s)-13 week(s) intermittent inhalation-rat TCLo; 180 mg/kg/30 day(s) 

intermittent intraperitoneal-rat TDLo; 210 μg/m3/5 year(s) intermittent 

inhalation-man TCLo; 0.3 mg/m3/5 hour(s)-26 week(s) intermittent inhalationrat TCLo; 0.3 mg/m3/5 hour(s)-26 week(s) intermittent inhalation-monkey TCLo; 

0.7 mg/m3/24 hour(s)-22 week(s) continuous inhalation-rat TCLo; 0.7 

mg/m3/24 hour(s)-22 week(s) continuous inhalation-mouse TCLo; 250 mg/m3/1 

year(s) intermittent inhalation-human TCLo; 0.5 mg/m3/39 week(s) intermittent 

inhalation-human TCLo; 200 mg/kg/20 day(s) intermittent oral-rat TDLo; 216 

mg/kg/15 week(s) intermittent intraperitoneal-rat TDLo; 144 mg/kg/5 week(s) 

intermittent intraperitoneal-rat TDLo; 24,mg/kg/5 week(s) intermittent 

unreported-rat TDLo; 72 mg/kg/5 week(s) intermittent unreported-rat TDLo; 

57.6 mg/kg/4 week(s) intermittent intraperitoneal-rat TDLo; 0.71 mg/m3/2 

hour(s)-10 day(s) intermittent inhalation-rat; 5.25 mg/kg/21 day(s) intermittent 

oral-rat; 185 mg/kg/37 day(s) continuous oral-rat TDLo

Acute Toxicity Level: Slightly Toxic (ingestion)

Target Organs: Nervous System

Conditions Aggravated By Exposure: History of alcoholism, blood system disorders, liver disorders, nervous system 

disorders, and respiratory disorders.

Tumorigenic Data: 400 mg/kg intramuscular-rat TDLo/1 year(s) intermittent 

Mutagenic Data: Dominant lethal test - rat intraperitoneal 25 mg/kg

Reproductive Effects Data: 50 mg/kg oral-rat TDLo 20 day(s) post pregnancy continuous; 322.5 mg/kg 

oral-mouse TDLo 43 day(s) male; 1,290 mg/kg oral-mouse TDLo 43 day(s) 

male; 0.71 mg/m3 inhalation-rat TCLo 15-16 day(s) pregnant female 

continuous; 0.71 mg/m3 inhalation-rat TCLo multigenerations; 90 mg/kg oralrat TDLo 18 day(s) post pregnancy continuous

Additional Data: Symptoms may depend on a combination of contributing factors including 

genetic predisposition, age, nutrition, anemia or alcohol.

Iron

Toxicity Data: 77 mg/kg oral-child TCLo; 30 gm/kg oral-rat LD50; 20 mg/kg intraperitonealrabbit LDLo; 20 gm/kg oral-guinea pig LD50; 200 mg/kg oral-human LD50; 63 

gm/kg/6 week(s) continuous oral-rat TCLo; 250 mg/m3/6 hour(s)-4 week(s) 

intermittent inhalation-rat TCLo; 150 mg/m3/4 hour(s)-78 week(s) intermittent

inhalation-rat TCLo; 105 mg/kg/5 week(s) continuous oral-rat TCLo; 16800 

mg/kg/4 week(s) continuous oral-rat TDLo ; 41.4 mg/kg/2 week(s) intermittent 

subcutaneous-mouse TDLo ; 219.6 gm/kg/183 day(s) continuous oral-rat TDLo

Carcinogen Status: Iron itself has not been evaluated by IARC. However iron and steel founding 

has been evaluated as IARC Group 1 (Human Sufficient Evidence). Studies 

have shown that certain exposures in iron and steel founding can cause lung 

cancer in humans. Excesses lf leukemia and urogenital and digestive system 

cancers have also been reported. 

Acute Toxicity Level: Relatively Non-Toxic (ingestion)

Tumorigenic Data: 450 mg/kg intratracheal-rat TDLo/15 weeks intermittent 

Aluminum Oxide

Toxicity Data: >3600 mg/kg intraperitoneal-mouse LD50; 200 mg/m3/5 hour(s)-28 week(s) 

intermittent inhalation-rat TCLo; 200 mg/m3/5 hour(s)-28 weeks intermittent 

inhalation-rabbit 

Carcinogen Status: ACGIH; A4-Not Classifiable as a Human Carcinogen (Aluminum insoluble 

compounds)

Medical Conditions Aggravated by 

Exposure: Respiratory disorders

Tumorigenic Data: 90 mg/kg intrapleural-rat TDLo; 200 mg/kg implant-rat TDLo; 200 mg/kg 

implant-rat TD
Manganese, Metallurgical Safety Data Sheet

Format: GHS Revised: April 24, 2015

Language: English (US) Version 2

Page 13 of 16

Silicon Dioxide

Toxicity Data: >200 gm/m3/1 hour(s) inhalation-rat LC; 1 mg/kg intratracheal-rat TDLo; 224 

mg/kg/4 week(s) continuous oral-dog TDLo

Carcinogen Status: Human Inadequate Evidence, Animal Inadequate Evidence, Group 3 

(Amorphous silica)

Medical Conditions Aggravated by 

Exposure: Respiratory disorders

Quartz

Toxicity Data: 16 mppcf/8 hour(s)-17.9 year(s) intermittent inhalation-human TCLo; 300

ug/m3/10 year(s) intermittent inhalation-human LCLo; 90 mg/kg intravenousrat LDLo; 200 mg/kg intratracheal-rat LDLo; 40 mg/kg intravenous mouse LDLo;

>20 mg/kg intratracheal-mouse LD; 20 mg/kg/ intravenous-dog LDLo; 200 

mg/kg inhalation-rat TCLo; 250 mg/kg intratracheal-rat LDLo; 240 mg/kg/1 

hour(s) intratracheal-rat TDLo; 1.5 mg/kg intratracheal-rat TDLo; 120 gm/kg 

oral-rat TDLo; 15.69 mg/kg intratracheal-rat TDLo; 16.7 mg/kg intratrachealmouse TDLo; 40 mg/kg inhalation-mouse TDLo; 25 mg/kg intratracheal-rat

TDLo; 20 mg/kg implant-rabbit TDLo; 80 mg/kg intratracheal-mouse TDLo; 150 

mg/kg intratracheal-rat TDLo; 100 mg/kg intratracheal-rat TDLo; 100 mg/kg 

intratracheal-mouse TDLo; 1 mg/kg inhalation-rat TDLo; 10 mg/kg 

intratracheal-rat TDLo; 1250 ug/kg intratracheal-rat TDLo; 100 mg/kg 

intratracheal-rat TDLo; 30 mg/kg intratracheal rat TDLo; 50 mg/kg intratrachealrat TDLo; 5 mg/kg intratracheal-rat TDLo; 1 mg/kg intratracheal-rat TDLo; 80 

mg/ m3/26 weeks intermittent inhalation-rat TCLo; 108 mg/m3/6 hour(s)-3 

day(s) intermittent inhalation-rat TCLo ; 58 mg/m3/13 week(s) intermittent 

inhalation-rat TCLo; 1475 ug/m3/8 hour(s)-21 week(s) intermittent inhalationmouse TCLo; 4932 ug/m3/24 hour(s)- 39 week(s) continuous inhalationmouse TCLo; 28 mg/m3/3 week(s) intermittent inhalation-guinea pig TCLo; 3 

mg/m3/6 hour(s)-78 week(s) intermittent inhalation-hamster TCLo; 1000 

gm/m3/10 day(s) intermittent inhalation-domestic animal TCLo; 2.88 mg/kg/12 

week(s) intermittent intratracheal-rat TCLo; 11.52 mg/kg/12 week(s) 

intermittent intratracheal-rat TCLo; 15 mg/m3/26 week(s) intermittent 

inhalation-rat TCLo; 0.74 mg/m3/2 year(s) intermittent inhalation-rat TCLo; 10

mg/m3/75 day(s) intermittent inhalation-rat TCLo; 10 mg/m3/818 day(s) 

intermittent inhalation-monkey TCLo; 240 ug/m3/12 week(s) intermittent 

intratracheal-rat TCLo; 960 ug/kg/12 week(s) intermittent intratracheal rat 

TCLo; 160 mg/kg/2 week(s) intermittent inhalation-mouse TCLo; 6.2 mg/ m3/6 

hour(s)-6 week(s) intermittent inhalation-rat TCLo; 15 mg/m3/79 day(s) 

intermittent inhalation-rat TCLo; 300 ug/kg/12 week(s) intermittent 

intratracheal rat TCLo; 25 mg/ m3/5 day(s) intermittent inhalation-rat TCLo 

Carcinogen Status: NTP: Known Human Carcinogen; IARC: Human Sufficient Evidence, Animal 

Sufficient Evidence, Group 1; ACGIH: A2- Suspected Human Carcinogen; EC: 

Category 2 Adenocarcinomas and squamous-cell carcinomas of the lung in 

rats were produced after inhalation or repeated intratracheal instillation of 

various forms of crystalline silica. Malignant lymphomas developed in rats after 

intrapleural and intraperitoneal injections of quartz suspensions and 

intrapleural injection of cristobalite and tridymite. Epidemiologic studies 

indicate lung cancer occurs more frequently among silicotics than in the 

general population. 

Medical Conditions Aggravated By 

Exposure: respiratory disorders

Tumorigenic Data: 50 mg/kg inhalation-rat TCLo/6 hour(s)-71 week(s) intermittent; 45 mg/kg 

intraperitoneal-rat TCLo; 90 mg/kg intravenous-rat TDLo; 90 mg/kg intrapleuralrat TDLo; 111 mg/kg intratracheal-rat TDLo; 100 mg/kg intratracheal-rat 

TDLo/19 weeks intermittent; 900 mg/kg implant-rat TDLo; 4000 mg/kg implantmouse TDLo; 84 mg/kg intrapleural-hamster TDLo; 90 mg/kg intraperitonealrat TD/4 week(s) intermittent; 450 mg/kg intrapleural-rat TD; 100 mg/kg 

intrapleural-rat TD

Mutagenic Data: Micronucleus test-human lung 40 ug/cm2; micronucleus test-hamster lung 160 
Manganese, Metallurgical Safety Data Sheet

Format: GHS Revised: April 24, 2015

Language: English (US) Version 2

Page 14 of 16

ug/cm2; DNA damage-rat intratracheal 3 mg/kg

Additional Data: Smoking may enhance the toxic effects. 

Lead

Toxicity Data: 450 mg/kg/6 year(s) oral-woman TDLo; 10 ug/m3 inhalation-human TCLo; 1 

gm/kg intraperitoneal – rat LDLo; 160 mg/kg oral-pigeon LDLo; 271 mg/m3

inhalation-human LCLo; 155 mg/kg oral-rat TDLo; 50 mg/kg intraperitonealrabbit TDLo; 88 mg/kg parenteral-chicken TDLo; 0.2 mg/kg oral-rat TDLo; 1050 

ug/kg/30 week(s) intermittent oral-rat TDLo; 6879 mg/kg/5 week(s) continuous 

oral-mouse TDLo; 20 mg/m3/6 hour(s)-30 day(s) intermittent inhalation-guinea 

pig TCLo; 200 ug/m3/6 hour(s)-26 week(s) intermittent inhalation-guinea pig 

TCLo; 582 mg/kg/30 day(s) continuous oral-non-mammalian species TDLo;

4099.2 mg/kg/8 week(s) intermittent oral-mouse TDLo; 10248 mg/kg 20 

week(s) intermittent oral-mouse TDLo; 9.9 mg/m3/122 day(s) intermittent 

inhalation-human TCLo; 0.011 mg/m3/26 week(s) intermittent inhalationhuman TCLo; 0.012 mg/kg/10 day(s) intermittent unreported-rat TDLo; 120 

mg/kg/60 day(s) intermittent unreported-horse, donkey TDLo; 93.6 mg/kg/30 

day(s) continuous oral-rat TDLo; 0.03 mg/m3/1 year(s) intermittent inhalationman TCLo; 0.03 mg/m3/5 year(s) intermittent inhalation-man TCLo; 0.109 

mg/m3/5 year(s) intermittent inhalation-man TCLo; 43.75 mg/kg/1 week(s) 

continuous oral-rat TDLo;

Carcinogen Status: IARC: Human Limited Evidence, Animal Inadequate Evidence, Group 2A 

(Inorganic lead compounds); ACGIH: A3-Confirmed Animal Carcinogen

Renal tumors were produced in animals by lead acetate, lead subacetate, and 

lead phosphate given orally, subcutaneously, or intraperitoneally. Two studies 

in rats exposed to lead powder orally or by intramuscular injection and one 

study on intrarenal injection did not produce tumors. 

Target Organs: nervous system, kidneys, teratogen

Medical Conditions Aggravated By 

Exposure: blood system disorders, gastrointestinal disorders, nervous system disorders, 

respiratory disorders

Mutagenic Data: cytogenetic analysis- human unreported 50 ug/m3; cytogentic analysis – rat 

inhalation 23 ug/m3 16 week(s); cytogenetic analysis – monkey oral 42 mg/kg 

30 week(s); DNA damage- human inhalation 4.2 ng/L 6 year(s) – intermittent

Reproductive Effects Data: 790 mg/kg oral-rat TCLo multigenerations; 1140 mg/kg oral-rat TCLo 14 day(s) 

pre pregnancy/21 day(s) post pregnancy continuous; 520 mg/kg oral-rat TCLo

7-22 day(s) pregnant female/10 day(s) post pregnancy continuous; 1100 

mg/kg oral-rat TCLo 1-22 day(s) pregnant female continuous; 10 mg/m3

inhalation-rat TCLo/24 hour(s) 1-21 day(s) pregnant female continuous; 3 

mg/m3 inhalation-rat TCLo/24 hour(s) 1-21 day(s) pregnant female continuous; 

1120 mg/kg oral-mouse TCLo multigenerations; 6300 mg/kg oral-mouse TCLo

1-21 day(s) pregnant female continuous; 300 mg/kg oral-mouse TCLo 1-2 

day(s) pregnant female continuous; 4800 mg/kg oral-mouse TCLo 1-16 day(s) 

pregnant female continuous; 662 mg/kg oral-domestic animal TCLo 1-21 

week(s) pregnant female continuous; 814 mg/kg oral-domestic animal TCLo

15 day(s) post pregnancy continuous; 4099.2 mg/kg oral-mouse TCLo 56 

day(s) male; 24 ug/kg oral-mouse TCLo multigenerations; 1545 gm/kg oral-rat 

TCLo 8 week(s) pre pregnancy/21 day(s) post pregnancy continuous. 

Additional Data: May cross the placenta. Smoking may result in higher blood lead levels. May 

be excreted in breast milk. 

12.1 Ecotoxicity

No data available.

12.2 Persistence and Degradability

Section 12: Ecological Information
Manganese, Metallurgical Safety Data Sheet

Format: GHS Revised: April 24, 2015

Language: English (US) Version 2

Page 15 of 16

No data available.

12.3 Bioaccumulative Potential

No data available.

12.4 Mobility in Soil

No data available.

12.5 Other Adverse Effects

No data available.

Dispose in accordance with all applicable regulations. Hazardous Waste Number(s): D008. Dispose of in accordance with U.S. 

EPA 40 CFR 262 for concentrations at or above the regulatory level. Regulatory level-5.0 mg/L. 

14.1 UN Number 

UN Number: Not applicable.

14.2 UN Proper Shipping Name

UN Proper Shipping Name: Not applicable.

14.3 Transport Hazard Class(es)

U.S. Department of Transportation: No classification assigned.

CA Transportation/Dangerous Goods: No classification assigned.

Land Transport ADR: No classification assigned. 

Land Transport RID: No classification assigned. 

Air Transport IATA: No classification assigned. 

Air Transport ICAO: No classification assigned.

Maritime Transport IMDG: No classification assigned.

14.4 Packing Group

No classification assigned.

14.5 Environmental Hazards

No data available.

14.6 Transport in Bulk

No data available.

14.7 Special Precautions

No data available.

US Regulations

CERCLA 102A/103 (40 CFR 302.4): Lead: 10 lbs. RQ (solid metal particles < 100 micrometer diameter (0.004 

inches))

Section 13: Disposal Considerations

Section 14: Transport Information

Section 15: Regulatory Information
Manganese, Metallurgical Safety Data Sheet

Format: GHS Revised: April 24, 2015

Language: English (US) Version 2

Page 16 of 16

SARA Title III 

Section 302 (40 CFR 355.30): Not regulated.

Section 304 (40 CFR 355.40): Not regulated.

Sections 311/312 (40 CFR 370.21): Yes (Acute, Chronic)

Section 313 (40 CFR 372.65): Yes (Aluminum Oxide (Alumina) (fibrous forms), Manganese and Compounds 

{as Mn}, lead)

OSHA Process Safety: Not regulated.

State Regulations

California Proposition 65: Lead: Cancer (Oct 01, 1992); Developmental toxicity (Feb 27, 1987); Male 

reproductive toxicity (Feb 27, 1987); Female reproductive toxicity (Feb 27, 

1987)

Canadian Regulations: WHMIS Classification: Not determined.

European Regulations: EC Classification (calculated): Not determined. 

National Inventory Status

U.S. Inventory (TSCA): Listed on inventory.

TSCA 12(b) Export Notification: Not listed.

The information in this Safety Data Sheet meets the requirements of the United States Department of Labor OCCUPATIONAL 

SAFETY AND HEALTH ADMINISTRATION and regulations promulgated thereunder (29 CFR 1910.1200 et. seq.). This 

document is intended only as a guide to the appropriate precautionary material handling by a person trained in, or supervised 

by a person trained in, chemical handling. Exposure to this chemical may have serious adverse health effects. This chemical 

may interact with other substances. Since the potential uses are so varied, all of the potential hazards of use or interaction 

with other chemicals or materials cannot be identified on this Safety Data Sheet. The user should recognize that this chemical 

can cause injury, especially if improperly handled, precautionary measures are not followed, and personal protective 

equipment not worn. Read and understand all precautionary information prior to use. The Defense Logistics Agency (DLA) 

shall not be held liable for any damage resulting from handling or from contact with the above chemical.

References:

ChemAdvisor, Inc. Material Safety Data Sheet: Ferromanganese, High Carbon. Revision Date: January 27, 2009. 

American Conference of Governmental Industrial Hygienists. 2013 TLVs® and BEIs®, ACGIH® Publication #0113. 2013.

US Department of Transportation. Emergency Response Guidebook. 2012

Centers for Disease Control and Prevention. NIOSH Pocket Guide to Chemical Hazards, http://www.cdc.gov/niosh/npg/.

National Institute of Health, Toxicology Data Network. http://toxnet.nlm.nih.gov/

NOTE: No data available: no data for this topic found using references listed.

Date of Preparation of Updated SDS: February 8, 2017

Section 16: Other Information